Company Quick10K Filing
Maximus
10-Q 2021-03-31 Filed 2021-05-06
10-Q 2020-12-31 Filed 2021-02-04
10-K 2020-09-30 Filed 2020-11-19
10-Q 2020-06-30 Filed 2020-08-06
10-Q 2020-03-31 Filed 2020-05-07
10-Q 2019-12-31 Filed 2020-02-06
10-K 2019-09-30 Filed 2019-11-26
10-Q 2019-06-30 Filed 2019-08-08
10-Q 2019-03-31 Filed 2019-05-09
10-Q 2018-12-31 Filed 2019-02-07
10-K 2018-09-30 Filed 2018-11-20
10-Q 2018-06-30 Filed 2018-08-09
10-Q 2018-03-31 Filed 2018-05-10
10-Q 2017-12-31 Filed 2018-02-08
10-K 2017-09-30 Filed 2017-11-20
10-Q 2017-06-30 Filed 2017-08-03
10-Q 2017-03-31 Filed 2017-05-04
10-Q 2016-12-31 Filed 2017-02-09
10-K 2016-09-30 Filed 2016-11-21
10-Q 2016-06-30 Filed 2016-08-04
10-Q 2016-03-31 Filed 2016-05-06
10-Q 2015-12-31 Filed 2016-02-05
10-K 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-07
10-Q 2015-03-31 Filed 2015-05-08
10-Q 2014-12-31 Filed 2015-02-06
10-K 2014-09-30 Filed 2014-11-17
10-Q 2014-06-30 Filed 2014-08-08
10-Q 2014-03-31 Filed 2014-05-09
10-Q 2013-12-31 Filed 2014-02-07
10-K 2013-09-30 Filed 2013-11-19
10-Q 2013-06-30 Filed 2013-08-09
10-Q 2013-03-31 Filed 2013-05-10
10-Q 2012-12-31 Filed 2013-02-08
10-K 2012-09-30 Filed 2012-11-16
10-Q 2012-06-30 Filed 2012-08-08
10-Q 2012-03-31 Filed 2012-05-04
10-Q 2011-12-31 Filed 2012-02-03
10-K 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-09
10-Q 2011-03-31 Filed 2011-05-10
10-Q 2010-12-31 Filed 2011-02-08
10-K 2010-09-30 Filed 2010-11-19
10-Q 2010-06-30 Filed 2010-08-05
10-Q 2010-03-31 Filed 2010-05-06
10-Q 2009-12-31 Filed 2010-02-04
8-K 2020-11-23
8-K 2020-08-11
8-K 2020-06-19
8-K 2020-05-12
8-K 2020-04-03
8-K 2020-03-23
8-K 2020-02-10
8-K 2019-11-22
8-K 2019-08-12
8-K 2019-08-02
8-K 2019-05-13
8-K 2019-03-29
8-K 2019-03-22
8-K 2019-02-11
8-K 2019-01-16
8-K 2019-01-10
8-K 2018-12-14
8-K 2018-11-26
8-K 2018-10-09
8-K 2018-08-13
8-K 2018-05-14
8-K 2018-03-15
8-K 2018-02-12
8-K 2018-01-16

Maximus Financials

MMS Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash1771832041731912301691891671871881261211311831581491158275516151667095104166197253229349625479116
Accounts Receivable115138126147150141158173199205221273278310275263265340378396425433421444426432377394439415399358487492526477
Inventory
PP&E11912111511812112413514258596318173717221583103118299138137136328122113107274969185273817785330
Assets5375735905655846166526957067447598588448979229018929551,2761,2801,2761,3431,2981,3491,2961,3161,2831,3511,4021,4301,4011,4621,6691,6881,6911,746
Accounts Payable54626255626761
Long-Term Debt12222222222111116721124528621116615111616112120750
Liabilities180190194191192205222244244251268328305325334345334367635664663679593596534493393405394364345376552520476498
Stockholders' Equity3573833963743924114304514624934915305395725895565585876386126096597027497598208869401,0011,0631,0521,0841,1151,1651,2141,248
Income Statement ($MM)2010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue214227238250240245266301286326334384407439420435467529572579557606617623608622600621623613598558665737731755
Cost of Revenue158164172182180179188216210229240267301379307322348398429453447459466470463470448458471464443420505567556587
Gross Profit5663666860657985779795117106121113113119131144125110148151153145152152163152149155139159169174168
R&D
SG&A293435353338444342474960535957625459676064667068656968827073707480788282
Tax10111210202421172426282519293129272727222024241720302123
Net Income171820261814202421332836344134364247423627495351475358556055604656626360
Cash Flow ($MM)2010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating3063427284116301029503242358948575119251208672716611585387972134596813693
Cash Investing-5-6-6-10-1-5-72-8-10-8-17-95-8-11-11-20-14-33-315-31-13-48-14-12-7-5-5-8-6-7-28-5-412-8-21-43
Cash Financing-54-9-41-11-0-2-4-21-1-18-2-37-13-29-48-48-51621-1138-81-43-57-38-103-18-1-17-66-859-68-91-11